A study of Herceptin (trastuzumab) in combination therapy in patients with metastatic breast cancer

Next Previous
Trial Profile

A study of Herceptin (trastuzumab) in combination therapy in patients with metastatic breast cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Apr 2010

At a glance

  • Drugs Cyclophosphamide; Epirubicin; Trastuzumab
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Acronyms HERCULES
  • Sponsors Roche

    • Most Recent Events

    • 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
    • 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
    • 22 Feb 2010 Results published in the Journal of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top